We have signed up to the new Future Science Group Journals ‘Read & Publish’ Transitional Agreement 2021-2022. This agreement offers read access to 20 hybrid journals along with immediate open access publishing in these titles and FSG’s 15 fully open access titles for all authors at participating institutions, for all article types, for a fixed fee.

Future Science Group publishes 35 STM journals across three imprints: Future Medicine Ltd, Future Science Ltd and Newlands Press Ltd. Journals cover basic and clinical areas of biomedicine, and the portfolio includes titles such as BioTechniques, Future Oncology, Nanomedicine, Epigenomics, Immunotherapy, Bioanalysis, and Regenerative Medicine.

A title list can be found at https://www.futuremedicine.com/action/showPublications?pubType=journal and https://www.future-science.com/action/showPublications?pubType=journal all available titles have been added to DiscoverEd.